Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
646 |
|
| Actual shortage: | 62 (10%) | |
| Anticipated shortage: | 11 (2%) | |
| Avoided shortage: | 16 (2%) | |
| Resolved: | 557 (86%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
20 (25%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| FUROSEMIDE | 20MG | TABLET | Resolved | 2025-04-01 | 2025-06-14 | 253774 |
| FUROSEMIDE | 40MG | TABLET | Resolved | 2025-07-09 | 2025-09-18 | 262262 |
| FUROSEMIDE | 40MG | TABLET | Anticipated shortage | 2025-12-08 | 2025-12-08 | 273634 |
| FUROSEMIDE | 80MG | TABLET | Anticipated shortage | 2025-12-08 | 2025-12-08 | 273637 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-10-10 | 2017-10-27 | 24913 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2017-11-22 | 2017-12-22 | 30110 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-12-15 | 2017-12-22 | 33110 |
| GABAPENTIN | 800MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114766 |
| GABAPENTIN | 600MG | TABLET | Resolved | 2020-05-11 | 2020-10-21 | 114770 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-08-29 | 2023-10-23 | 203128 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2023-10-23 | 2023-11-14 | 207859 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2023-11-22 | 2024-03-08 | 211055 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-01-30 | 2024-03-14 | 217766 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2024-02-26 | 2024-06-19 | 220627 |
| GABAPENTIN | 400MG | CAPSULE | Resolved | 2024-03-25 | 2024-08-03 | 223259 |
| GABAPENTIN | 100MG | CAPSULE | Resolved | 2024-05-28 | 2024-10-08 | 228997 |
| GABAPENTIN | 800MG | TABLET | Actual shortage | 2024-07-03 | 2024-12-02 | 232020 |
| GABAPENTIN | 300MG | CAPSULE | Avoided shortage | 2024-08-19 | 2024-09-04 | 235471 |
| GABAPENTIN | 300MG | CAPSULE | Resolved | 2024-11-18 | 2024-12-19 | 243265 |
| GALANTAMINE ER | 8MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-05-11 | 2021-02-10 | 114761 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |